Eur J Intern Med 71:2331 Yazaki Y, Isobe M, Takahashi W, Kitabayashi H, Nishiyama O, Sekiguchi M, Takemura T (1999) Assessment of myocardial fatty acid metabolic abnormalities in patients with idiopathic dilated cardiomyopathy using 123I BMIPP SPECT: correlation with clinicopathological findings and clinical course
The latter was similar to the benefit seen with the injectable version of semaglutide
Patients need to adjust the dose reasonably under the guidance of a doctor to avoid discontinuing treatment due to side effects
However, only the injectable form has been available because peptide drugs are usually not suitable for administration via the oral route, as they present low oral bioavailability, are inactivated when they reach the gastrointestinal tract, and have low rates of diffusion into the cell [31, 32]
For patients with type 2 diabetes, reduced potency may manifest as elevated hemoglobin A1c levels , increased fasting glucose readings, or loss of previously achieved glycemic control